PF-Atlas › Clinical Trials › NCT00981747

Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

Sildenafil · Phase 2

Registry ID
NCT00981747
Phase
Phase 2
Status
Terminated
Drug / intervention
Sildenafil
Sponsor
Alicia Gerke
Start
2009-09
Enrollment
12
Locations
1

About this trial

The purpose of this study is to determine whether combination therapy with sildenafil and losartan can improve function and exercise tolerance in patients with idiopathic pulmonary fibrosis.

View NCT00981747 on ClinicalTrials.gov →

Explore related

All Sildenafil trialsAll IPF trials

Related trials

sildenafil — NCT00359736Sildenafil — NCT00352482sildenafil — NCT00659529Sildenafil — NCT01194232Sildenafil — NCT02057458sildenafil — NCT02626182
Medical disclaimer. This page summarizes public trial data for NCT00981747 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.